Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-4332Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)-Peak areaPAK Untreated
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+1706Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+2565Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+2567Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+3175Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+3322Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+4271Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+8134Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+Peak areaPAK Untreated

Return to search page
  logo